|
US5750119A
(en)
*
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
AU724399B2
(en)
*
|
1995-08-18 |
2000-09-21 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6773707B1
(en)
*
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
CA2265935C
(en)
|
1996-09-20 |
2006-09-05 |
The University Of New Mexico |
Heat shock protein complexes
|
|
US6455493B1
(en)
|
1996-09-20 |
2002-09-24 |
University Of New Mexico |
Methods for using heat shock proteins
|
|
US7157089B1
(en)
*
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US7514232B2
(en)
*
|
1996-12-06 |
2009-04-07 |
Becton, Dickinson And Company |
Method for detecting T cell response to specific antigens in whole blood
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US6709672B2
(en)
*
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
WO1999002989A1
(en)
*
|
1997-07-10 |
1999-01-21 |
Medical Research Council |
Chaperone fragments
|
|
ATE231917T1
(de)
*
|
1997-08-05 |
2003-02-15 |
Stressgen Biotechnologies Corp |
Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine
|
|
US6007821A
(en)
*
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
AU761432B2
(en)
*
|
1997-10-31 |
2003-06-05 |
Sloan-Kettering Institute For Cancer Research |
Conjugate heat shock protein-binding peptides
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
ES2439014T3
(es)
|
1998-02-20 |
2014-01-21 |
The University Of Miami |
Complejo de péptido antigénico-proteína de choque térmico modificada
|
|
WO1999048914A1
(en)
*
|
1998-03-26 |
1999-09-30 |
The University Of New Mexico |
Methods for using heat shock proteins
|
|
ES2246566T5
(es)
*
|
1998-03-27 |
2010-10-26 |
Gabriele Prof. Dr. Multhoff |
Aplicacion de proteinas hsp70.
|
|
AU2004200711B2
(en)
*
|
1998-08-19 |
2005-11-10 |
Immunobiology Limited |
Vaccine Comprising Cytokine-Induced Heat Shock Proteins (HSP)
|
|
GB9818133D0
(en)
*
|
1998-08-19 |
1998-10-14 |
Quadrant Holdings Cambridge |
Vaccine
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
US6495360B1
(en)
|
1999-05-28 |
2002-12-17 |
Photogen, Inc. |
Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
|
|
EP1196772A2
(en)
*
|
1999-07-08 |
2002-04-17 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
WO2001023421A2
(en)
*
|
1999-09-30 |
2001-04-05 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
US20010034042A1
(en)
*
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
US7235649B2
(en)
*
|
2000-03-24 |
2007-06-26 |
Duke University |
Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
|
|
US7186515B1
(en)
|
2000-06-02 |
2007-03-06 |
University Of Connecticut Health Center |
Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
US7179462B2
(en)
|
2000-06-02 |
2007-02-20 |
University Of Connecticut Health Center |
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
AU6669401A
(en)
|
2000-06-02 |
2001-12-11 |
Univ Connecticut Health Ct |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
IL153474A0
(en)
*
|
2000-06-26 |
2003-07-06 |
Stressgen Biotechnologies Corp |
Human papilloma virus treatment
|
|
EP1322325A4
(en)
*
|
2000-07-20 |
2004-09-15 |
Merck & Co Inc |
INHIBITION OF PROCESSING AND REPLICATION OF HEPATITIS C VIRUS
|
|
EP1363938B1
(en)
*
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
AU2001292674A1
(en)
*
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
WO2002024220A2
(en)
*
|
2000-10-18 |
2002-03-28 |
Tengiz Jaliashvili |
Vaccine comprising heat stress proteins from herbaceous plants
|
|
US20020172682A1
(en)
*
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US6892140B1
(en)
|
2000-11-27 |
2005-05-10 |
Enteron, Inc. |
Immunogenic cancer peptides and uses thereof
|
|
WO2002062959A2
(en)
|
2001-02-05 |
2002-08-15 |
Stressgen Biotechnologies Corp. |
Hepatitis b virus treatment
|
|
US6855925B2
(en)
*
|
2001-02-14 |
2005-02-15 |
Picoliter Inc. |
Methods, devices, and systems using acoustic ejection for depositing fluid droplets on a sample surface for analysis
|
|
US6875849B2
(en)
*
|
2001-05-01 |
2005-04-05 |
Arizona Board Of Regents Of Behalf Of The University Of Arizona |
Methods of recovering chaperone proteins and complexes thereof
|
|
RU2182480C1
(ru)
*
|
2001-05-16 |
2002-05-20 |
Хохлов Александр Петрович |
Противоопухолевый препарат и способ его получения
|
|
US7169564B1
(en)
|
2001-06-26 |
2007-01-30 |
Anaderm Research Corporation |
FKBP51/52 and CyP40-mediated mammalian hair growth
|
|
PL375043A1
(en)
*
|
2001-08-20 |
2005-11-14 |
University Of Connecticut Health Center |
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin, useful for the treatment of cancer and infectious disease
|
|
US20030211971A1
(en)
*
|
2001-09-17 |
2003-11-13 |
Srivastava Pramod K. |
Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
|
|
WO2003029419A2
(en)
*
|
2001-10-01 |
2003-04-10 |
Duke University |
Three dimensional structure of crystalline grp94 binding domain, and its methods of use
|
|
US20030194409A1
(en)
*
|
2002-01-17 |
2003-10-16 |
Rothman James E. |
Conjugate heat shock protein-binding peptides
|
|
US7048756B2
(en)
*
|
2002-01-18 |
2006-05-23 |
Apasara Medical Corporation |
System, method and apparatus for evaluating tissue temperature
|
|
US6850804B2
(en)
*
|
2002-01-18 |
2005-02-01 |
Calfacior Corporation |
System method and apparatus for localized heating of tissue
|
|
US6993394B2
(en)
|
2002-01-18 |
2006-01-31 |
Calfacion Corporation |
System method and apparatus for localized heating of tissue
|
|
US7118753B2
(en)
*
|
2002-02-08 |
2006-10-10 |
Anawrahta Biotech Co., Ltd. |
Enhancing cell-based immunotherapy
|
|
EP1572933A4
(en)
*
|
2002-02-13 |
2007-09-05 |
Univ Duke |
MODULATION OF THE IMMUNE RESPONSE BY POLYPEPTIDES AS AN ANSWER TO NONPEPTIDIC BINDING STRENGTH
|
|
WO2003072595A2
(en)
*
|
2002-02-28 |
2003-09-04 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
|
US8088569B2
(en)
*
|
2002-03-01 |
2012-01-03 |
Applied Immune Technologies |
Immunogens for treatment of neoplastic and infectious disease
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
AU2003231098A1
(en)
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2003092624A2
(en)
*
|
2002-05-02 |
2003-11-13 |
University Of Connecticut Health Center |
Use of heat shock proteins to enhance efficacy of antibody therapeutics
|
|
US20030206916A1
(en)
*
|
2002-05-03 |
2003-11-06 |
Rush-Presbyterian-St. Luke's Medical Center |
Immunogenic peptides
|
|
WO2004035084A2
(en)
*
|
2002-10-02 |
2004-04-29 |
Diamyd Medical Ab |
Formulation of glutarmic acid decarboxylase (gad65) and serum albumin
|
|
JP2006516091A
(ja)
*
|
2002-10-07 |
2006-06-22 |
アンティジェニクス インコーポレーテッド |
熱ショックタンパク質結合性のｃｄ９１断片およびその使用
|
|
CA2503457A1
(en)
*
|
2002-10-25 |
2004-05-06 |
University Of Connecticut Health Center |
Apparatus and method for immunotherapy of a cancer through controlled cell lysis
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
DE602004030541D1
(de)
|
2003-02-20 |
2011-01-27 |
Univ Connecticut Health Ct |
Verfahren zur herstellung von alpha (2) makroglobulin-antigen-molekül-komplexen
|
|
CA2514500A1
(en)
*
|
2003-02-20 |
2004-09-10 |
University Of Connecticut Health Center |
Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
|
|
ATE553113T1
(de)
*
|
2003-02-28 |
2012-04-15 |
Agenus Inc |
Verwendung von lektinen zur förderung der oligomerisierung von glycoproteinen und antigenen molekülen
|
|
US7309491B2
(en)
*
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
WO2004098526A2
(en)
*
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
KR100516389B1
(ko)
*
|
2003-09-08 |
2005-09-23 |
한국과학기술원 |
작은 열 충격 단백질을 함유하는 단백질 분해 방지용조성물 및 이를 이용한 이차원 전기영동법
|
|
EP2289547B1
(en)
|
2003-09-12 |
2015-12-16 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
US8399972B2
(en)
*
|
2004-03-04 |
2013-03-19 |
Skyworks Solutions, Inc. |
Overmolded semiconductor package with a wirebond cage for EMI shielding
|
|
EP1841452B8
(en)
|
2004-10-08 |
2014-06-11 |
Domantis Limited |
Single domain antibodies against tnfr1 and methods of use therefor
|
|
WO2006073970A2
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
WO2007050978A2
(en)
*
|
2005-10-29 |
2007-05-03 |
University Of Connecticut |
Methods for the elimination of pathogens and other particulate agents
|
|
WO2007058957A2
(en)
*
|
2005-11-10 |
2007-05-24 |
Point Therapeutics, Inc |
Boroproline compound and cytokine combination therapy
|
|
US20100330105A1
(en)
*
|
2006-08-22 |
2010-12-30 |
John Hopkins University |
Anticancer Combination Therapies
|
|
US9320794B2
(en)
|
2006-11-13 |
2016-04-26 |
Immunovative Therapies, Ltd. |
Ablative immunotherapy
|
|
US7972594B2
(en)
|
2006-11-13 |
2011-07-05 |
Immunovative Therapies Ltd. |
Ablative immunotherapy
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
US20110027315A1
(en)
*
|
2007-09-07 |
2011-02-03 |
Allen Harmsen |
Protein cages and their uses
|
|
EP2257301B1
(en)
|
2008-03-03 |
2014-01-22 |
The University of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
US20120128656A1
(en)
|
2008-05-02 |
2012-05-24 |
Immunovative Therapies, Ltd. |
Vaccine compositions and methods
|
|
US20110250173A1
(en)
|
2010-04-13 |
2011-10-13 |
Immunovative Therapies Ltd. |
Methods and compositions for inhibition of Treg cells
|
|
EP2484371B1
(en)
|
2008-06-26 |
2014-12-17 |
Orphazyme APS |
Use of Hsp70 as a regulator of enzymatic activity
|
|
WO2010060026A1
(en)
*
|
2008-11-21 |
2010-05-27 |
University Of Miami |
Hiv/siv vaccines for the generation of mucosal and systemic immunity
|
|
AU2010232490B2
(en)
|
2009-04-03 |
2016-08-11 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
GB0910591D0
(en)
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
GB0916557D0
(en)
|
2009-09-21 |
2009-10-28 |
Health Prot Agency |
Commensal neisserial stress protein complexes
|
|
RU2013125923A
(ru)
|
2010-11-30 |
2015-01-10 |
Орфазиме Апс |
СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
|
|
EP2734231A1
(en)
*
|
2011-07-21 |
2014-05-28 |
Biotech Tools S.A. |
Dosage of dnak
|
|
US10709700B2
(en)
|
2014-09-15 |
2020-07-14 |
Orphazyme A/S |
Arimoclomol formulation
|
|
KR20170109582A
(ko)
|
2015-02-06 |
2017-09-29 |
히트 바이오로직스, 인코퍼레이티드 |
벡터 공동 발현 백신 및 공동 자극 분자
|
|
EP3294324A1
(en)
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
EP3442530A1
(en)
|
2016-04-13 |
2019-02-20 |
Orphazyme A/S |
Heat shock proteins and cholesterol homeostasis
|
|
SI3448382T1
(sl)
|
2016-04-29 |
2021-03-31 |
Orphazyme A/S, c/o COBIS A/S |
Arimoclomol za zdravljenje motenj, povezanih z glukocerebrozidazo
|
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
US11548930B2
(en)
|
2017-04-04 |
2023-01-10 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
KR20210005646A
(ko)
|
2018-04-26 |
2021-01-14 |
아게누스 인코포레이티드 |
열쇼크 단백질-결합 펩티드 조성물 및 그의 이용 방법
|
|
WO2022106614A1
(en)
|
2020-11-19 |
2022-05-27 |
Orphazyme A/S |
Processes for preparing arimoclomol citrate and intermediates thereof
|
|
CN115490768B
(zh)
*
|
2021-06-18 |
2024-11-15 |
佛山热休生物技术有限公司 |
Col1a1的表位肽及所述表位肽与热休克蛋白的复合物
|